Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Neurocysticercosis D020019 1 associated lipids
Telangiectasia, Hereditary Hemorrhagic D013683 1 associated lipids
Hemosiderosis D006486 1 associated lipids
Rickets, Hypophosphatemic D063730 1 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Gilbert Disease D005878 2 associated lipids
Fasciitis D005208 2 associated lipids
Restless Legs Syndrome D012148 2 associated lipids
Hyperbilirubinemia, Hereditary D006933 3 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Carcinogenesis D063646 3 associated lipids
Biliary Tract Diseases D001660 3 associated lipids
Addison Disease D000224 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Anemia, Refractory D000753 3 associated lipids
Testicular Neoplasms D013736 5 associated lipids
Glucosephosphate Dehydrogenase Deficiency D005955 5 associated lipids
Osteomalacia D010018 5 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Thrombophlebitis D013924 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Jaundice, Neonatal D007567 7 associated lipids
Leprosy D007918 8 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Myocardial Stunning D017682 10 associated lipids
Hearing Disorders D006311 10 associated lipids
Hepatitis D006505 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Dehydration D003681 11 associated lipids
Iron Overload D019190 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Hypocalcemia D006996 12 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Critical Illness D016638 13 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Anemia D000740 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Balázová E et al. Antitumor activity of four polymer bound trans-1,2-diaminocyclohexaneplatinum(II)-4-carboxyphtalate complexes tested in different model systems. 1986 Neoplasma pmid:3808121
Hrubisko M et al. Drug resistance induction and cross-resistance studies with Pt-complexes. 1984 Neoplasma pmid:6542968
Fernández-Gallego J et al. [Treatment with intravenous iron and ferritin level]. 2010 Nefrologia pmid:20514109
Faber F et al. Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. 2016 Nature pmid:27309805
Dueber JE et al. Synthetic protein scaffolds provide modular control over metabolic flux. 2009 Nat. Biotechnol. pmid:19648908
DeLisa MP and Conrado RJ Synthetic metabolic pipelines. 2009 Nat. Biotechnol. pmid:19668178
Gomollón F and Gisbert JP IBD: Intravenous iron in IBD--what's the best preparation? 2011 Nat Rev Gastroenterol Hepatol pmid:21788975
McLean AE Cancer and nutrition (review). 1976 Nahrung pmid:781541
Auerbach M and Rodgers GM Intravenous iron. 2007 N. Engl. J. Med. pmid:17611217
Kriebel D et al. Detection of occupational exposure to genotoxic agents with a urinary mutagen assay. 1983 Mutat. Res. pmid:6835232
Scassellati-Sforzolini G et al. In vivo studies on genotoxicity of pure and commercial linuron. 1997 Mutat. Res. pmid:9186570
Grote L et al. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. 2009 Mov. Disord. pmid:19489063
Richens A et al. Effects of sodium valproate on the serum protein binding of phenytoin, and on liver enzyme activity. 1980 Monogr Neural Sci pmid:6798427
Bartels H et al. [Relations between lipoprotein X and gamma glutamyltransferase in serum and D-saccharic acid in urine of mature, healthy newborn infants]. 1976 Monatsschr Kinderheilkd pmid:6906
Xia B et al. A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut. 2012 Mol. Pharm. pmid:23033922
Li LO et al. Early hepatic insulin resistance in mice: a metabolomics analysis. 2010 Mol. Endocrinol. pmid:20150186
Sienkiewicz-Porzucek A et al. Mild reductions in mitochondrial NAD-dependent isocitrate dehydrogenase activity result in altered nitrate assimilation and pigmentation but do not impact growth. 2010 Mol Plant pmid:20035036
Menendez C et al. Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? 2011 Mol Nutr Food Res pmid:22144045
Wyffels L et al. Detection of myocardial ischemia-reperfusion injury using a fluorescent near-infrared zinc(II)-dipicolylamine probe and 99mTc glucarate. 2012 Mol Imaging pmid:22554483
Biggar P and Hahn KM [Importance of the different i.v. iron generations for everyday medical practice]. 2013 MMW Fortschr Med pmid:23678667
Kosch M and Schaefer RM [Iron deficiency. When parenteral substitution?]. 2001 MMW Fortschr Med pmid:11247361
Filisetti P et al. [D-glucaric acid. A new method proposed to investigate damage from exposure to anesthetic gas and vapors]. 1990 Minerva Anestesiol pmid:2084591
Teschke O et al. Quorum sensing detected by atomic force microscopy imaging of corrals surrounding multicellular arrangement of bacteria. 2008 Microsc. Res. Tech. pmid:17943987
Kinouchi T et al. In vitro intestinal microflora-mediated metabolism of biliary metabolites from 1-nitropyrene-treated rats. 1987 Microbiol. Immunol. pmid:3451027
De Saint-Hubert M et al. Molecular imaging of cell death. 2009 Methods pmid:19362149
Moon TS et al. Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. 2010 Metab. Eng. pmid:20117231
De Sousa A and Kalra G Drug therapy of attention deficit hyperactivity disorder: current trends. 2012 Mens Sana Monogr pmid:22654382
Nomoto H et al. A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report. 2017 Medicine (Baltimore) pmid:28953654
Deng Y et al. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. 2017 Med. Sci. Monit. pmid:28285317
Ren X et al. Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study. 2015 Med. Sci. Monit. pmid:26175087
Hedenus M and Birgegård G The role of iron supplementation during epoietin treatment for cancer-related anemia. 2009 Med. Oncol. pmid:18473194
Séronie-Vivien S et al. Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report. 2003 Med. Oncol. pmid:14514981
Marselos M et al. Aldehyde dehydrogenase inducibility and ethanol preference in rats. 1975 Med. Biol. pmid:810629
Franco G et al. Behaviour of urinary D-glucaric acid excretion in surgical patients and anaesthesiology staff acutely exposed to isoflurane and nitrous oxide. 1991 Nov-Dec Med Lav pmid:1803214
Maroni M et al. Evaluation of porphyrinogenesis and enzyme induction in workers exposed to PCB. 1984 May-Jun Med Lav pmid:6148686
Loi AM et al. [Urinary secretion of D-glucaric acid in subjects exposed to styrene]. 1984 Mar-Apr Med Lav pmid:6749047
Volpi R et al. [Increased urinary excretion of D-glucaric acid in workers exposed to styrene in reinforced plastics industry]. 1988 Mar-Apr Med Lav pmid:3173231
Apostoli P et al. [Behavior of urinary D-glucaric acid in occupational exposure to inorganic lead]. 1987 Sep-Oct Med Lav pmid:3447026
Tutor JC et al. [Calcium metabolism and liver enzyme induction in patients treated with anticonvulsant drugs]. 1984 Med Clin (Barc) pmid:6145829
García Erce JA et al. [Thoughts about the usefulness of the preoperatory administration of intravenous iron in hip fracture surgery]. 2013 Med Clin (Barc) pmid:23790583
Blanco Rubio N et al. [Preoperative intravenous iron as a strategy for blood saving in surgery for hip fracture]. 2013 Med Clin (Barc) pmid:23246172
Muñoz M et al. [Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients]. 2009 Med Clin (Barc) pmid:19264195
Izuel Rami M et al. [Budget impact analysis of a blood saving program for urgent traumatological surgery]. 2007 Med Clin (Barc) pmid:17266885
Fujita K et al. Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). 2000 Life Sci. pmid:10821120
Brunelle FM and Verbeeck RK Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat. 1997 Life Sci. pmid:9180355
Curley RW et al. Activity of D-glucarate analogues: synergistic antiproliferative effects with retinoid in cultured human mammary tumor cells appear to specifically require the D-glucarate structure. 1994 Life Sci. pmid:8190001
Budillon G et al. D-glucaric acid excretion during chenodeoxycholate therapy for gallstones. 1978 Lancet pmid:74626
de Wolff FA et al. Valproate induces urinary D-glucaric acid excretion. 1981 Lancet pmid:6111706
Hunter J et al. Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. 1971 Lancet pmid:4100904
Aarts EM D-glucaric-acid excretion as a test for hepatic enzyme induction. 1971 Lancet pmid:4102545
Hunter J et al. D-glucaric-acid excretion as a test for hepatic enzyme induction. 1971 Lancet pmid:4103690
Edwards OM et al. Changes in cortisol metabolism following rifampicin therapy. 1974 Lancet pmid:4140269
Krafft A et al. Erythropoietic quality of maternal milk. 1999 Lancet pmid:10475225
Hu Q et al. Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. 2010 Lab. Invest. pmid:20065947
Yoon J et al. Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement. 2010 Korean J. Intern. Med. pmid:21179286
Okada M et al. Hypophosphatemia induced by intravenous administration of Saccharated iron oxide. 1983 Klin. Wochenschr. pmid:6843038
Blaustein DA et al. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. 2003 Kidney Int. Suppl. pmid:14531777
Keven K et al. Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. 2005 Kidney Int. pmid:15954940
Agarwal R Is i.v. iron really superior in CKD patients not on dialysis? 2006 Kidney Int. pmid:16957750
Zager RA Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. 2005 Kidney Int. pmid:16164630
Agarwal R Proinflammatory effects of iron sucrose in chronic kidney disease. 2006 Kidney Int. pmid:16609688
Deicher R et al. High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. 2003 Kidney Int. pmid:12846772
Agarwal R Transferrin saturation with intravenous irons: an in vitro study. 2004 Kidney Int. pmid:15327409
Aronoff GR et al. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. 2004 Kidney Int. pmid:15327417
Zager RA et al. Parenteral iron nephrotoxicity: potential mechanisms and consequences. 2004 Kidney Int. pmid:15200421
Sengoelge G et al. Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. 2004 Kidney Int. pmid:15200437
Zager RA et al. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. 2016 Kidney Int. pmid:27165818
Agarwal R et al. A randomized trial of intravenous and oral iron in chronic kidney disease. 2015 Kidney Int. pmid:26083656
Vikrant S Optimum dosage regimen for iron sucrose. 2007 Kidney Int. pmid:17625585
Agarwal R et al. Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2007 Kidney Int. pmid:17622274
Jaber BL Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. 2008 Kidney Int. pmid:18235527
Lim R et al. A permanent tan from iron. 2008 Kidney Int. pmid:18340355
Auerbach M and Al Talib K Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. 2008 Kidney Int. pmid:18274543
Schaller G et al. Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. 2005 Kidney Int. pmid:16316358
Van Wyck DB et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. 2005 Kidney Int. pmid:16316362
Zheng H et al. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. 2006 Kidney Int. pmid:16395269
Almilaji A et al. Regulation of the voltage gated K channel Kv1.3 by recombinant human klotho protein. 2014 Kidney Blood Press. Res. pmid:25571875
Tanaka H et al. [A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)]. 1982 Kansenshogaku Zasshi pmid:6809855
Higashi T et al. [Relative Ga-67 image enhancement by iron-loading]. 1984 Kaku Igaku pmid:6593479
Furuno K et al. Influence of dehydration and D-glucarate on distribution and excretion of kanamycin in rats. 1977 Jpn. J. Pharmacol. pmid:916384
Furuno K et al. Effect of D-glucaric acid derivatives on stability of rat liver lysosomes and erythrocytes. 1974 Jpn. J. Pharmacol. pmid:4463271
Hinohara Y et al. Glucuronic acid pathway in alloxan diabetic rabbits. (I). Urinary excretion of metabolites related to the glucuronic acid pathway. 1974 Jpn. J. Pharmacol. pmid:4463273
Tsuruoka T et al. Inhibition of pulmonary metastases and tumor cell invasion in experimental tumors by sodium D-glucaro-delta-lactam (ND2001). 1995 Jpn. J. Cancer Res. pmid:7737908
Tsuruoka T et al. Inhibition of tumor cell haptotaxis by sodium D-glucaro-delta-lactam (ND2001). 1995 Jpn. J. Cancer Res. pmid:8567400
Adhikary L and Acharya S Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. 2011 Jul-Sep JNMA J Nepal Med Assoc pmid:22922860
Smith TG et al. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. 2009 JAMA pmid:19809026
Lynn S and McDaniel J Managing severe anemia when the patient is a Jehovah's Witness. 2013 JAAPA pmid:23610833
Gorder V et al. Treatment of restless legs syndrome with iron infusion therapy. 2009 JAAPA pmid:19354112
Yamamoto S et al. Iatrogenic osteomalacia: report of two cases. 2013 J. UOEH pmid:23475021
Wang Y et al. Hepatoprotective effects of kombucha tea: identification of functional strains and quantification of functional components. 2014 J. Sci. Food Agric. pmid:23716136
Kaltwasser JP et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. 2001 J. Rheumatol. pmid:11708414
Kolodziejczyk J et al. In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. 2011 J. Physiol. Biochem. pmid:21086198
Tutor-Crespo MJ et al. Effect of antiepileptic drugs on the urinary excretion of porphyrins in non-porphyric subjects. 2005 J. Pharmacol. Sci. pmid:16314692
Bologa M et al. Pregnancy-induced changes in drug metabolism in epileptic women. 1991 J. Pharmacol. Exp. Ther. pmid:2033516
Patel IH et al. Induction effect of phenobarbital on the carbamazepine to carbamazepine-10, 11-epoxide pathway in rhesus monkeys. 1981 J. Pharmacol. Exp. Ther. pmid:7229992
Tanaka E et al. Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene. 1982 J. Pharmacobio-dyn. pmid:7097483
Garnham JC et al. The effect of repeated administration of diftalone on enzyme induction. 1978 J. Pharm. Pharmacol. pmid:27604
Oleson L and Court MH Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. 2008 J. Pharm. Pharmacol. pmid:18718121
Latham AN D-Glucaric acid as an index of hepatic enzyme induction by anticonvulsant drugs in man. 1974 J. Pharm. Pharmacol. pmid:4151390
Latham AN Effect of in vitro changes in urinary pH on the enzymatic measurement and daily variation in excretion of D-glucaric acid. 1975 J. Pharm. Pharmacol. pmid:239180